Chief Financial Officer of Alignment Healthcare, Inc. (NASDAQ:ALHC), Robert Thomas Freeman, has recently sold shares in the company amounting to over $64,000. This transaction took place on two consecutive days, with a range of share prices from $10.00 to $10.08.
The sale, which was executed in multiple transactions, saw Freeman dispose of a total of 6,439 shares. On the first day, 1,640 shares were sold at $10 each, followed by a smaller transaction of 10 shares at $10.01. The subsequent day, 4,789 shares were traded at a weighted-average price of $10.0048, with individual sales ranging from $10.00 to $10.08 per share.
Following these transactions, Freeman's indirectly held remaining shares in Alignment Healthcare are substantial. The shares sold were owned by FCO Holdings LLC, a limited liability company controlled by FCO Holdings Trust One, an irrevocable trust of which Freeman is an indirect beneficiary.
Investors and followers of Alignment Healthcare will note this activity as a part of the ongoing financial developments within the company. The details of the sale, including the number of shares sold at each price point within the range, are available upon request from the company or the Securities and Exchange Commission.
The transactions were disclosed in accordance with SEC regulations, and the full information regarding the sales has been made available for public record.
In other recent news, Alignment Healthcare has undergone significant board changes and signed a consulting agreement with a former board member. Board members Jeffrey Margolis and Thomas Carella have resigned, though their departures are not linked to any operational, policy, or practice disagreements. Margolis has entered a consulting agreement with Alignment Healthcare's primary operating subsidiary, which includes an initial payment and varying monthly retainers until June 30, 2026.
The company has also seen robust growth, with a 56% increase in health plan membership and a 47% surge in revenue year-over-year. This performance has led to an upward adjustment in year-end membership expectations and a forecast of at least 20% growth in 2025. In response to these results, Baird, TD Cowen, and Piper Sandler have all raised their stock price targets for Alignment Healthcare.
These recent developments continue to make Alignment Healthcare an interesting prospect for investors, as the company focuses on profitability and expanding its national footprint. It is important to note that these are recent developments and should be considered in the context of the company's overall performance and future plans.
InvestingPro Insights
Amidst the recent share sales by Alignment Healthcare's CFO, Robert Thomas Freeman, the company's stock has demonstrated a robust performance in the market. According to InvestingPro data, Alignment Healthcare has experienced a significant return over the last year, with a one-year price total return of 73.54%. This strong momentum is further highlighted by a considerable six-month price total return of 83.24%, showcasing investor confidence and market interest in the company.
Despite these impressive returns, InvestingPro Tips suggest caution. Analysts have revised their earnings downwards for the upcoming period, indicating potential headwinds for the company's financial outlook. Furthermore, Alignment Healthcare operates with a moderate level of debt and is trading near its 52-week high, which stands at 93.5% of the peak price. These factors may influence investor strategies and valuation considerations.
For those closely monitoring Alignment Healthcare's financial health, the company's Price / Book ratio as of the last twelve months stands at 14.69, which is on the higher end, suggesting a premium valuation. Additionally, the company's gross profit margin during the same period was 10.65%, which may be a point of concern for investors looking for stronger profitability metrics.
Investors interested in a deeper analysis of Alignment Healthcare, including additional InvestingPro Tips, can find more detailed insights and metrics at https://www.investing.com/pro/ALHC. Currently, there are 11 additional tips available on InvestingPro, offering a comprehensive view of the company's financial standing and market potential.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.